Screener
Exagen Inc. XGN Total Revenue
Total Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Exagen Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 9:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001274737-26-000029
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $17,306 | $15,498 |
| Cost of revenue | 7,101 | 6,375 |
| Gross profit | 10,205 | 9,123 |
| Operating expenses: | ||
| Selling, general and administrative expenses | 12,066 | 11,204 |
| Research and development expenses | 1,553 | 1,284 |
| Total operating expenses | 13,619 | 12,488 |
| Loss from operations | (3,414) | (3,365) |
Item 1. Financial Statements
FAQ
- What is Exagen Inc.'s total revenue?
- Exagen Inc. (XGN) reported total revenue of $17.31M in Q1 2026.
- How has Exagen Inc.'s total revenue changed year-over-year?
- Exagen Inc.'s total revenue increased by 11.7% year-over-year, from $15.5M to $17.31M.
- What is the long-term trend for Exagen Inc.'s total revenue?
- Over 4 years (2021 to 2025), Exagen Inc.'s total revenue has grown at a 8.4% compound annual growth rate (CAGR), from $48.3M to $66.58M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Exagen Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude